drugset / Trial / NCT01763580

A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic Syndrome

NCT01763580

Phase 4 Completed 144 enrolled Astellas Pharma Inc
RandomizedParallel-groupOpen-labelTreatment

Summary

To compare the therapeutic effect of tacrolimus in combination with low-dose corticosteroid with high-dose corticosteroid alone in patients with minimal-change nephrotic syndrome.

Timeline

Start
2012-07-16
Primary completion
2017-05-02
Completion
2017-08-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Prednisolone Other / unclassified Oral
Subject Tacrolimus Small molecule Oral